Establishment Labs (ESTA) Stock Drops on Dec. 18, 2025 After a Fresh 52-Week High as Analysts Lift Price Targets
Establishment Labs Holdings Inc. (NASDAQ: ESTA) has become one of the more closely watched mid-cap medtech stories of late 2025—surging to new highs this week, then snapping back sharply on Thursday, December 18.
Shares of Establishment Labs ended the day at $70.01, down about 6.3%, after trading in a wide intraday range between $69.74 and $76.02. That pullback follows a powerful multi-session run that pushed the stock to fresh peaks earlier this week, including an intraday high of $78.24 on December 17. [1]
The timing matters: the decline hit just as Wall Street price targets have been moving higher and the company continues to point to improving profitability metrics and strong U.S. traction for its Motiva platform.
